Review Article
Peripheral T-Cell Lymphoma: Review and Updates of Current Management Strategies
Table 1
List of T-cell lymphomas adapted from the 2008 WHO classification of mature T-cell and NK-cell Neoplasms.
| Cutaneous | | (i) Mycosis fungoides | | (ii) Sezary syndrome | | (iii) Primary cutaneous CD30+ T-cell lymphoproliferative disorders | | (iv) Primary cutaneous anaplastic large-cell lymphoma | | (v) Primary cutaneous γδ T-cell lymphoma | | (vi) Primary cutaneous CD8+ aggressive epidermotropic lymphoma | | (vii) Primary cutaneous CD4+ small/medium T-cell lymphoma | |
| Nodal | | (i) Angioimmunoblastic T-cell lymphoma | | (ii) Anaplastic large-cell lymphoma, ALK positive | | (iii) Anaplastic large-cell lymphoma, ALK negative | | (iv) Peripheral T-cell lymphoma, NOS | |
| Extranodal | | (i) Systemic EBV+ T-cell childhood lymphoproliferative disorder | | (ii) Hydroa vacciniforme-like lymphoma | | (iii) Extranodal NK/T-cell lymphoma, nasal type | | (iv) Enteropathy-associated T-cell lymphoma | | (v) Hepatosplenic T-cell lymphoma | | (vi) Subcutaneous panniculitis-like T-cell lymphoma | |
| Leukemic | | (i) T-cell prolymphocytic leukaemia | | (ii)T-cell large-granular lymphocytic leukaemia | | (iii) Adult T-cell leukaemia/lymphoma | |
|
|